EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H32N6O4S2 |
| Net Charge | 0 |
| Average Mass | 544.703 |
| Monoisotopic Mass | 544.19265 |
| SMILES | Cc1oc2nc1C(=O)N[C@@H](C(C)C)c1nc(cs1)C(=O)N[C@@H](C(C)C)c1nc(cs1)C(=O)N[C@H]2C(C)C |
| InChI | InChI=1S/C25H32N6O4S2/c1-10(2)16-23-31-19(13(7)35-23)22(34)30-18(12(5)6)25-27-15(9-37-25)21(33)29-17(11(3)4)24-26-14(8-36-24)20(32)28-16/h8-12,16-18H,1-7H3,(H,28,32)(H,29,33)(H,30,34)/t16-,17-,18-/m0/s1 |
| InChIKey | YGMRMAIELLDBHQ-BZSNNMDCSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Lissoclinum bistratum (ncbitaxon:322849) | - | PubMed (12608858) |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| bistratamide H (CHEBI:65507) has role antineoplastic agent (CHEBI:35610) |
| bistratamide H (CHEBI:65507) has role metabolite (CHEBI:25212) |
| bistratamide H (CHEBI:65507) is a homodetic cyclic peptide (CHEBI:24613) |
| bistratamide H (CHEBI:65507) is a macrocycle (CHEBI:51026) |
| IUPAC Name |
|---|
| (4S,11S,18S)-7-methyl-4,11,18-tri(propan-2-yl)-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.15,8.112,15]tetracosa-1(21),5(24),7,12(23),14,19(22)-hexaene-2,9,16-trione |
| Manual Xrefs | Databases |
|---|---|
| 10250991 | ChemSpider |
| Registry Numbers | Sources |
|---|---|
| Reaxys:9453180 | Reaxys |
| Citations |
|---|